Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2018-06-08
2018-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim 1: To examine whether the addition of hummus as part of an afternoon snack will improve diet quality, particularly through assessments of daily:
* Vegetable consumption
* Snacking behavior
* Energy intake
* Food choices
Aim 2: To examine whether the addition of hummus as part of an afternoon snack will improve appetite control and satiety including assessments of:
* Appetite Control (hunger, desire to eat, prospective food consumption)
* Cravings (sweet, salty, savory)
* Satiety (fullness)
* Eating initiation
Aim 3: To examine whether the addition of hummus as part of an afternoon snack will improve free-living glycemic control.
Aim 4: To explore whether the addition of hummus as part of an afternoon snack will improve mood/energy states
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Snacks and Satiety
NCT03947281
Effect of Food Acceptability on Appetite Hormones' Response in Normal Weight vs. Obese Male Subjects
NCT03779321
A Comparison of Satiety Effects Two Commercially Available Snack Bars
NCT07227701
High Fat vs High Protein and Appetite Hormones
NCT04518930
The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control
NCT02480582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Snack
The study participants will be provided with a snack to consume every day of the week. The energy content of the snacks will be standardized to \~240 kcal. The snacks will have different levels of protein, fat, carbohydrates, sugar, and fiber.
Snack
Hummus and Pretzels- The study participants will be provided with a hummus and pretzels snack to consume every day for a week. The energy content of the hummus and pretzels will be \~240 kcal. The hummus and pretzels contain 6 g protein, 27 g carbohydrates, 0 g sugar, 4 g fiber, and 12 g fat.
Granola Bars- The study participants will be provided with two granola bars to consume every day for a week. The energy content of the two granola bars will be \~240 kcal. The two granola bars contain 4 g protein, 38 g carbohydrates, 16 g sugar, 2 g fiber, and 9 g fat.
No Snack
The study participants will not be provided with any snack and will be told to consume nothing from 2-4pm for a week.
No Snack
The study participants will not be provided with any snack and will be told to consume nothing from 2-4pm for a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Snack
Hummus and Pretzels- The study participants will be provided with a hummus and pretzels snack to consume every day for a week. The energy content of the hummus and pretzels will be \~240 kcal. The hummus and pretzels contain 6 g protein, 27 g carbohydrates, 0 g sugar, 4 g fiber, and 12 g fat.
Granola Bars- The study participants will be provided with two granola bars to consume every day for a week. The energy content of the two granola bars will be \~240 kcal. The two granola bars contain 4 g protein, 38 g carbohydrates, 16 g sugar, 2 g fiber, and 9 g fat.
No Snack
The study participants will not be provided with any snack and will be told to consume nothing from 2-4pm for a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no metabolic, psychological, or neurological diseases/conditions not currently or previously on a weight loss or other special diet (in the past 6 months)
* non-smoking
* not been clinically diagnosed with an eating disorder
* habitually eat an afternoon snack between 2:00-4:00 pm
* no food allergies related to the study snacks
* rates the overall liking of hummus higher than "Neither Like nor Dislike" on the screening palatability questionnaire.
Exclusion Criteria
* Metabolic, hormonal, and/or neural conditions/diseases that influence metabolism or appetite
* Currently or previously on a weight loss or other special diet (in the past 6 months)
* Gained/lost \>10 lb. over the past 6 months
* Taking medication that would directly influence appetite (weight-loss drugs or antidepressant, steroid, or thyroid medication, unless dosage has been stable for at least 6 months)
* Not willing or able to complete all study testing procedures
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heather Leidy
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heather J Leidy, PhD
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1804020480
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.